| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Miedema F | |
| Schuitemaker H | |||
| Hamann D | |||
| Hazenberg MD | |||
| P2860 | cites work | Reduced rate of disease development after HIV-2 infection as compared to HIV-1 | Q28237927 |
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease | Q28267375 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
| Effect of HIV on thymic function before and after antiretroviral therapy in children | Q33180147 | ||
| Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues | Q33652519 | ||
| T cell dynamics in HIV-1 infection. | Q33683207 | ||
| Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection | Q33793153 | ||
| Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection | Q33817504 | ||
| Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. | Q33854488 | ||
| The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection | Q33904114 | ||
| Altered representation of naive and memory CD8 T cell subsets in HIV-infected children | Q34215632 | ||
| CD8 naive T cell counts decrease progressively in HIV-infected adults | Q34215781 | ||
| Thymic involution with ageing: obsolescence or good housekeeping? | Q34410911 | ||
| HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease | Q34560245 | ||
| In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline | Q35015256 | ||
| Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution | Q36048710 | ||
| Direct evidence for thymic function in adult humans | Q36375219 | ||
| Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy | Q36375293 | ||
| Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins | Q36377040 | ||
| Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen | Q36400677 | ||
| T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells | Q36557127 | ||
| Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy | Q36974912 | ||
| Factors influencing T-cell turnover in HIV-1-seropositive patients | Q37175631 | ||
| Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans | Q37366743 | ||
| High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. | Q37382323 | ||
| Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques | Q37412108 | ||
| Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease | Q40049075 | ||
| Lifespans of naive, memory and effector lymphocytes | Q40832453 | ||
| HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages | Q40931545 | ||
| Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. | Q41557849 | ||
| Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. | Q41611623 | ||
| T cell turnover in HIV-1 disease | Q41656290 | ||
| Rapid CD4+ T-cell turnover in HIV-1 infection: a paradigm revisited | Q41701875 | ||
| AIDS pathogenesis: a dynamic interaction between HIV and the immune system | Q41913909 | ||
| Antigen-independent activation of naive and memory resting T cells by a cytokine combination | Q42942555 | ||
| CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients | Q44518380 | ||
| Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection | Q44902494 | ||
| Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy | Q45745478 | ||
| Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution | Q45745490 | ||
| Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection | Q45752981 | ||
| Quantitation of human immunodeficiency virus type 1 in the blood of infected persons | Q45844274 | ||
| Effect of recent thymic emigrants on progression of HIV-1 disease | Q45865760 | ||
| Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort | Q45880593 | ||
| Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts | Q46721319 | ||
| Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy | Q47852642 | ||
| Normal telomere lengths in naive and memory CD4+ T cells in HIV type 1 infection: a mathematical interpretation. | Q52032408 | ||
| Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections. | Q52036600 | ||
| Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. | Q52040570 | ||
| Immunological and virological markers in individuals progressing from seroconversion to AIDS. | Q52097479 | ||
| Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. | Q52247397 | ||
| T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover | Q57204184 | ||
| Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume | Q57997617 | ||
| Thymus volume correlates with the progression of vertical HIV infection | Q57997658 | ||
| Changes in thymic function with age and during the treatment of HIV infection | Q59066353 | ||
| T cell activation and disease severity in HIV infection | Q62068077 | ||
| Programmed death of T cells in HIV-1 infection | Q67518695 | ||
| Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy | Q72356532 | ||
| T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host | Q73321259 | ||
| HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies | Q73321295 | ||
| Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation | Q73446061 | ||
| Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy | Q77754213 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 285-289 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock | |
| P478 | volume | 1 |
| Q44081130 | ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis |
| Q35828692 | Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. |
| Q36673915 | Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. |
| Q36812714 | Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus disease |
| Q44498209 | An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques |
| Q39665842 | Anatomical loci of HIV-associated immune activation and association with viraemia |
| Q35531527 | Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection |
| Q36600351 | Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development |
| Q37770721 | Antiretroviral therapy and management of HIV infection |
| Q36092837 | Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy. |
| Q36496226 | Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study |
| Q37629663 | Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach |
| Q37705556 | B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation |
| Q36752214 | Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication |
| Q36575593 | Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients |
| Q36742476 | CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo. |
| Q37195654 | CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection |
| Q42626503 | CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype. |
| Q51022678 | CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. |
| Q40815028 | CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease |
| Q59375800 | CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? |
| Q36223837 | CD4+ T-cell depletion in HIV infection: killed by friendly fire? |
| Q43693284 | Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly |
| Q35794660 | Cell-cycle dysregulation in the immunopathogenesis of AIDS. |
| Q39534825 | Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression |
| Q36483328 | Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics |
| Q33591190 | Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets |
| Q51960042 | Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. |
| Q27318086 | Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection |
| Q36926597 | Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells |
| Q33528999 | Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease |
| Q39683300 | Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia |
| Q36488962 | Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily |
| Q34720373 | Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis |
| Q34931908 | Development of alphabeta T cells in the human thymus |
| Q39996390 | Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques |
| Q33780497 | Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions |
| Q30391183 | Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy |
| Q35146353 | Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection |
| Q45068171 | Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses |
| Q34641904 | Effectiveness of a 'hunter' virus in controlling human immunodeficiency virus type 1 infection |
| Q34764588 | Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda |
| Q40611836 | Effects of chytridiomycosis on hematopoietic tissue in the spleen, kidney and bone marrow in three diverse amphibian species |
| Q51963727 | Effects of growth hormone in enhancing thymic regrowth and T-cell reconstitution. |
| Q42978531 | Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection |
| Q56903248 | Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development |
| Q36944118 | Evaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan |
| Q39377648 | Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines |
| Q34353915 | Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients |
| Q39605011 | Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals |
| Q43516931 | Expression of CD69 on T-cell subsets in HIV-1 disease. |
| Q35354848 | Expression of the IL-7 receptor alpha-chain is down regulated on the surface of CD4 T-cells by the HIV-1 Tat protein |
| Q37620568 | Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers |
| Q34500494 | GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals |
| Q36509765 | Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor |
| Q31066870 | Going wild: lessons from naturally occurring T-lymphotropic lentiviruses |
| Q42113280 | Grand Challenges in the Immunology of HIV and AIDS |
| Q30052157 | HIV and Tuberculosis: a Deadly Human Syndemic |
| Q41952863 | HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis |
| Q35585948 | HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS |
| Q24802813 | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells |
| Q37000907 | HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells |
| Q37427449 | HIV integration and T cell death: additional commentary. |
| Q43435654 | HIV tropism and CD4+ T-cell depletion |
| Q74221349 | HIV tropism and CD4+ T-cell depletion |
| Q33265220 | HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT |
| Q37029922 | HIV-1 Vpr: mechanisms of G2 arrest and apoptosis |
| Q35701633 | HIV-1 dynamics in vivo: implications for therapy |
| Q34500466 | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. |
| Q35372836 | HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection |
| Q26799782 | Hepatitis B and A vaccination in HIV-infected adults: A review |
| Q89426728 | High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi |
| Q37102101 | Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. |
| Q33724256 | Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline |
| Q37262403 | IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection |
| Q46610378 | IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation |
| Q33283061 | Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection |
| Q24648099 | Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors |
| Q37039032 | Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. |
| Q37199493 | Immune activation and collateral damage in AIDS pathogenesis. |
| Q35904496 | Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary |
| Q36590684 | Immune modulation by helminthic infections: worms and viral infections. |
| Q52606145 | Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets. |
| Q37417396 | Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy |
| Q27021524 | Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions |
| Q36673275 | Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys |
| Q35750901 | Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells |
| Q35149902 | Infection of dendritic cells by lymphocytic choriomeningitis virus |
| Q42140292 | Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors |
| Q36399551 | Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. |
| Q34598849 | Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers |
| Q39604683 | Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals |
| Q33707328 | Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus |
| Q37366730 | Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets |
| Q27499773 | Life and death as a T lymphocyte: from immune protection to HIV pathogenesis |
| Q35981519 | Limited role for the thymus in SIV pathogenesis |
| Q34052601 | Lineage-specific T-cell reconstitution following in vivo CD4+ and CD8+ lymphocyte depletion in nonhuman primates |
| Q35635026 | Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection |
| Q37154019 | Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa |
| Q50971339 | Microparticle delivery of Interleukin-7 to boost T-cell proliferation and survival. |
| Q36019742 | Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation |
| Q42142791 | Mycobacterial and HIV infections up-regulated human zinc finger protein 134, a novel positive regulator of HIV-1 LTR activity and viral propagation |
| Q38245228 | NK Cell Subset Redistribution during the Course of Viral Infections |
| Q59650907 | Naïve T Cells Are Maintained in the Periphery During the First3 Months of Acute HIV-1 Infection: Implications for Analysis of Thymus Function |
| Q34435083 | Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion |
| Q36938411 | Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses |
| Q45419109 | Pathogenesis of HIV infection: what the virus spares is as important as what it destroys |
| Q34007084 | Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo |
| Q33715552 | Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections |
| Q35616028 | Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts |
| Q44027886 | Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets |
| Q35022773 | Perturbations in B cell responsiveness to CD4 + T cell help in HIV-infected individuals |
| Q34301788 | Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys |
| Q37309633 | Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection |
| Q36953120 | Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection. |
| Q37167541 | Prevention of atherosclerosis in patients living with HIV. |
| Q40168499 | Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice |
| Q36229666 | Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection |
| Q36806548 | Quantifying T lymphocyte turnover |
| Q30448634 | R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression |
| Q37034630 | Rapid disease progression to AIDS due to Simian immunodeficiency virus infection of macaques: host and viral factors |
| Q35987907 | Rapid down-regulation of γc on T cells in early SIV infection correlates with impairment of T-cell function. |
| Q55281020 | Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy. |
| Q24562769 | Regeneration and tolerance factor prevents bystander T-cell death associated with human immunodeficiency virus infection |
| Q36602397 | Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals |
| Q36351352 | Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects |
| Q37547763 | Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques |
| Q36868753 | Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease |
| Q53467465 | Role of immune activation in CD4+ T-cell depletion in HIV-1 infected Indian patients. |
| Q37344397 | SCHOOL model and new targeting strategies |
| Q40300395 | Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore |
| Q34229707 | Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells |
| Q33771963 | Shaping successful and unsuccessful CD8 T cell responses following infection |
| Q37294337 | Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life |
| Q34360334 | Simian immunodeficiency virus selectively infects proliferating CD4+ T cells in neonatal rhesus macaques. |
| Q28950496 | Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome |
| Q36538762 | Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity |
| Q61797436 | Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment |
| Q34230673 | Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection |
| Q35108735 | Supervised interruptions of antiretroviral therapy |
| Q38984682 | Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. |
| Q89688886 | T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV |
| Q34981964 | T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus |
| Q33749278 | T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes |
| Q35849808 | The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus |
| Q36286495 | The HIV infection and immune activation: "to fight and burn". |
| Q42066659 | The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype |
| Q34619705 | The SCHOOL of nature: III. From mechanistic understanding to novel therapies |
| Q33966509 | The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition |
| Q33942992 | The dynamics of CD4+ T-cell depletion in HIV disease |
| Q27025707 | The enduring tale of T cells in HIV immunopathogenesis |
| Q33239691 | The integration hypothesis: an evolutionary pathway to benign SIV infection |
| Q37643739 | The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells |
| Q41773141 | The price of the CD27-CD70 costimulatory axis: you can't have it all. |
| Q34712821 | The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. |
| Q37053199 | The role of cytokines in the pathogenesis and treatment of HIV infection |
| Q36010933 | Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors |
| Q35847795 | Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys |
| Q33968350 | Turnover of lymphocytes and conceptual paradigms in HIV infection |
| Q36099429 | Understanding the benign nature of SIV infection in natural hosts |
| Q33285394 | Understanding the slow depletion of memory CD4+ T cells in HIV infection |
| Q35857688 | Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. |
| Q34173884 | Using death to one's advantage: HIV modulation of apoptosis |
| Q33707333 | Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan |
| Q35948038 | Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells |
| Q80858106 | [Advances in the immunopathology of HIV infection] |
Search more.